• Profile
Close

Effect of the EVO+ Visian phakic implantable collamer lens on visual performance, quality of vision and life: Objective and subjective outcomes after EVO+ implantation

American Journal of Ophthalmology Feb 14, 2021

Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. - In this prospective interventional case series, researchers sought to evaluate the impact of the EVO+ (V5) Visian implantable collamer lens implantation on mesopic visual performance, quality of vision (QoV) and quality of life (QoL). Thirty-six candidates (36 eyes) who underwent EVO+ implantation for myopia were assessed preoperatively and at postoperative visits 1 week, and 1, 3 and 6 months. During up to 6 months of follow-up, EVO+ implantation provides good mesopic visual performance, QoV and QoL. During the first postoperative week, some activities conducted under mesopic conditions with glare sources may be affected. Six months after surgery, ring-shaped dysphotopsia is negligibly bothersome.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay